Tag archive for ‘treatment of Parkinson’
Gil Tanenbaum On Friday, January 2nd, 2015

NeuroDerm Stock Doubles on Success of New Parkinson’s Drug

Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, ended the year on a really high note as its stock more than doubled in value this More...

Gil Tanenbaum On Monday, November 17th, 2014

NeuroDerm’s IPO Comes Up Short

– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on the NASDAQ, selling 4.5 million shares More...

Hillel Koren On Wednesday, October 29th, 2014

FDA Gives Phase III Nod to Intec Parkinson’s Treatment

– Intec Pharma says it expects the Phase III trial for its Accordion Pill Levodopa to take place in the second half of 2015.   Intec Pharma Ltd. (TASE: INTP) reported today that it had received US More...

Gil Tanenbaum On Thursday, August 28th, 2014

Neuroderm Raises $16 Million for Parkinson’s Cure

Israel’s NeuroDerm Ltd., announced that it raised $16 million to further the clinical and regulatory development of its Levodopa products, combating Parkinson’s disease. ND0612L, NeuroDerm’s More...

Gali Weinreb On Wednesday, May 21st, 2014

Neuroderm files for Nasdaq IPO

– The company has two products in clinical trials for the treatment of Parkinson’s. – – Transdermal drug delivery system developer Neuroderm Ltd. has filed a confidential draft prospectus More...

Wordpress site Developed by Fixing WordPress Problems